Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.20.1
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 43,565 $ 4,960
Marketable securities 71,826 112,904
Accounts receivable (including amounts from related parties of $6,404 and $1,050 as of March 31, 2020 and December 31, 2019, respectively) 9,079 6,298
Prepaid expenses and other current assets 2,989 4,406
Total current assets 127,459 128,568
Property and equipment, net 9,527 9,633
Marketable securities, non-current 14,191 15,609
Other non-current assets 2,683 2,545
Restricted cash 15 15
Total assets 153,875 156,370
Current liabilities:    
Accounts payable 5,839 5,584
Accrued compensation 2,944 6,017
Deferred revenue—current 22,873 19,465
Debt—current   1,000
Other current liabilities 352 901
Total current liabilities 32,008 32,967
Deferred revenue, non-current 15,113 16,195
Deferred rent 373 409
Debt—non-current 24,155 8,876
Other noncurrent liabilities 141 134
Total liabilities 71,790 58,581
Stockholders’ equity:    
Preferred stock, $0.001 par value — 10,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 0 shares issued and outstanding as of March 31, 2020 and December 31, 2019
Common stock, $0.001 par value — 300,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 23,227,421 and 23,098,969 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 23 23
Additional paid-in-capital 297,374 293,346
Accumulated other comprehensive income 28 165
Accumulated deficit (215,340) (195,745)
Total stockholders’ equity 82,085 97,789
Total Liabilities and Stockholders’ Equity $ 153,875 $ 156,370